We conclude that a future study with a larger sample size, complete verification, clear and unified inclusion and exclusion criteria, and a prospective and consecutive enrollment design is needed to rigorously estimate the diagnostic accuracy of OPN in diagnosis of ovarian cancer. This evidence concerns the gene SPP1 and ovarian carcinoma.